The Spectrum

8:00 – 9:00 a.m.

Registration and Breakfast

9:00 – 9:40 a.m.

Keynote: Peter Schultz, President & CEO, Scripps Research 
A New Model for Biomedical Research Institutes

9:40 – 10:40 a.m.

Scientific Session: Harnessing the Immune System

• Immuno-oncology Approaches
  • Travis Young, VP, Biologics, Calibr
• Immune System Regulators
  • Hugh Rosen, Professor, Department of Molecular Medicine, Scripps Research
• A Regulatory T-Cell Approach to Parkinson’s Disease
  • Sean Joseph, Director, Pharmacology, Calibr
• Rational Vaccine Strategies
  • Dennis Burton, Co-chair, Department of Immunology and Microbiology, Scripps Research

10:40 – 11:40 a.m.

Scientific Session: Regenerative Medicine and Aging

• Regenerative Medicine for Osteoarthritis
  • Kristen Johnson, Principal Investigator, Biology, Calibr
• Novel Approaches to Aging & Age-Related Disease
  • Michael Petrascheck, Associate Professor, Department of Molecular Medicine, Scripps Research
• Remyelination for Multiple Sclerosis
  • Luke Lairson, Assistant Professor, Department of Chemistry, Scripps Research
• Regeneration & Repair of the Heart & Lung
  • Michael Bollong, Scripps Fellow, Department of Chemistry, Scripps Research

11:40 a.m. - 12:45 p.m.

Lunch & Keynote: Trevor Mundel, President, Global Health Division, Bill & Melinda Gates Foundation
Found in Translation: How Innovations in Product R&D Can Solve the World’s Toughest Health Challenges

12:45 – 1:45 p.m.

Panel Discussion: The Role of Nonprofits in Accelerating Drug Discovery

Moderator: Chris Walsh, Consulting professor, Stanford University

• Brian Fiske, Senior VP, Research Programs, Michael J. Fox Foundation
• Ramy Ibrahim, CMO and VP, Clinical Development, Parker Institute for Cancer Immunotherapy
• Maria Millan, President and CEO, CIRM
• Trevor Mundel, President, Global Health Division, Bill & Melinda Gates Foundation
• Paul Negulescu, Senior VP and Site Head of SD Research, Vertex

1:45 – 2:45 p.m.

Scientific Session: Neglected and Childhood Disease

• Spread & Evolution of Deadly Pathogens
  • Kristian Andersen, Associate Professor, Department of Immunology and Microbiology, Scripps Research
• Preventing Malaria
  • Arnab Chatterjee, VP, Medicinal Chemistry, Calibr
• Novel Drugs for Autism-Spectrum Disorder
  • Gavin Rumbaugh, Associate Professor, Department of Neuroscience, Scripps Research
• Treatments for Diabetes
  • Nikki (Rogers) Alvarez, Associate Director, Alliances, Calibr

2:45 – 3:00 p.m.

Break

3:00 – 4:00 p.m.

Panel Discussion: Novel Funding Mechanisms for Biomedical Research

Moderator: James Schaeffer, UCLA Innovation Center, President, JMSchaeffer Consulting

• Dan Burgess, Venture Partner, SV Health Investors
• Kevin Eastwood, VP, Corporate Development, Calibr
• Carl Goldfischer, Managing Director, Bay City Capital
• Kathryn Richmond, Director, The Paul G. Allen Frontiers Group
• Barbara Sosnowski, VP and Global Head, External R&D Innovation Pharmatherapeutics and WRD External Partnerships, Pfizer

4:00 – 5:00 p.m.

Scientific Session: Novel Therapeutic Strategies

• Protein Homeostasis: Novel Strategies for Degenerative Diseases
  • Jeff Kelly, Professor, Department of Chemistry, Scripps Research
• Disease in a Dish for Precision Medicine
  • Kristin Baldwin, Professor, Department of Neuroscience, Scripps Research
• Directed Remodeling of the Gut Microbiome
  • Reza Ghadiri, Professor, Department of Chemistry, Scripps Research
• Therapeutics for Addiction Relapse & PTSD
  • Courtney Miller, Associate Professor, Department of Molecular Medicine, Scripps Research

5:00 – 5:30 p.m.

Cocktail Reception

5:30 – 7:30 p.m.

Dinner & Keynote: Eric Topol, Director & Founder, Scripps Research Translational Institute, Executive Vice President, Scripps Research
Deep Medicine